Clinical Data Management Applications & Studies

31. Actigraphy For Fibromyalgia 1/21/2020

    Fibromyalgia (FM) is a neuropathic pain that affects millions of people in the United States. It, like most pain conditions, affects daily activity and sleep. The pain sensations are best measured by recording the patient’s own perceptions (patient-reported outcome) but the related effects of pain on activity and sleep can be measured objectively with actigraphy. Read how actigraphy provides useful insights into the activity patterns in patients with fibromyalgia.

32. Actigraphy For Breast Cancer 1/21/2020

    Actigraphy is the measurement of motion used to monitor 24-hour activity patterns. Read how actigraphy was used in breast cancer studies to track sleep patterns, circadian endpoints as well as using datasets provided to investigate mathematical patterns which may be responsive to pharmacological therapy.

33. Actigraphy For Alzheimers 1/21/2020

    Alzheimer’s disease is a cognitive impairment, but it can manifest itself in many detrimental ways including alterations in daytime activity levels, sleep quality, and awake/sleep patterns. Read how actigraphy can provide important data when studying patients with Alzheimer's disease.

34. Actigraphy Motion Biosensors For Dermatology Poster Presentation 1/17/2020

    This poster demonstrates how the combination of high resolution actigraphy and advanced signal processing provides an accurate and non-invasive assessment of nocturnal scratching events.

35. Large PMA Study Of CRC Diagnostic 8/28/2019

    A study needed to enroll approximately 12,000 subjects and was also unique because it required subjects to self-collect samples at home. Read about the risk management and mitigation that Health Decisions utilized to keep the study on track.

36. Real-Time Monitoring Of The Digital Patient In Clinical Trials 6/7/2019

    This poster reports a framework for the real-time monitoring of subjects using wearable and patient-centric devices from multiple vendors. Wearable technology is a key component in the design of more patient-centric clinical trials.

37. The Stakes Were High In This Phase II Study, But The Risk Was Under Control 4/17/2018

    Software solutions provider adds value for a midsize pharmaceutical company from a quality, cost and study governance perspective by enabling them to implement risk-based (dynamic) approaches to monitoring.

38. Achieving Clinical Operations Excellence 8/30/2017

    Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.

39. Solutions For The Strategic Assessment Of Clinical Data In Trial Operations 8/29/2017

    Achieve clinical trial operations excellence using this an innovative solution that gives clinical operations organizations the unprecedented ability to reduce the time, cost, and risk of running clinical trials while accelerating time to market for products across the entire portfolio of clinical candidates.

40. eCOA Supports Successful Antianginal Trial 8/27/2017

    Gilead Sciences’ previous studies of Ranexa (ranolazine) relied on data from exercise treadmill parameters as the primary endpoint. But collecting data in this manner is costly, logistically challenging, and bears questionable clinical relevance — especially at the individual patient level. Learn how Gilead Sciences successfully utilized ERT handhelds to collect regulatory-compliant, patient-driven data in support of the primary efficacy endpoint in a Phase IV study of Ranexa.